Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Genetics

Free Subscription Articles published in J Clin Oncol Retrieve available abstracts of 22 articles: HTML format

Single Articles

February 2025
1. LEONG IUS, Cabrera CP, Cipriani V, Ross PJ, et al
   Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical Practice.
   J Clin Oncol. 2025;43:682-693.
   PubMed     Abstract available
   
   
   January 2025
2. YU EY, Rumble RB, Agarwal N, Cheng HH, et al
   Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline.
   J Clin Oncol. 2025 Jan 9:JCO2402608. doi: 10.1200/JCO-24-02608.
   PubMed     Abstract available
   
   
   October 2024
3. GOEL N, Hernandez A, Cole SW
   Social Genomic Determinants of Health: Understanding the Molecular Pathways by Which Neighborhood Disadvantage Affects Cancer Outcomes.
   J Clin Oncol. 2024;42:3618-3627.
   PubMed     Abstract available
   
   
   August 2024
4. TENTORI CA, Gregorio C, Robin M, Gagelmann N, et al
   Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes.
   J Clin Oncol. 2024;42:2873-2886.
   PubMed     Abstract available
   
   
   
5. CHANG TC, Chen W, Qu C, Cheng Z, et al
   Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia.
   J Clin Oncol. 2024 Aug 9:JCO2302238. doi: 10.1200/JCO.23.02238.
   PubMed     Abstract available
   
   
   
6. YOSHIMURA S, Li Z, Gocho Y, Yang W, et al
   Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia.
   J Clin Oncol. 2024 Aug 5:JCO2400500. doi: 10.1200/JCO.24.00500.
   PubMed     Abstract available
   
   
   July 2024
7. KATZ SJ, Abrahamse P, Furgal A, Hodan R, et al
   Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast Cancer.
   J Clin Oncol. 2024 Jul 15:JCO2400122. doi: 10.1200/JCO.24.00122.
   PubMed     Abstract available
   
   
   June 2024
8. NGUYEN NH, Dodd-Eaton EB, Corredor JL, Woodman-Ross J, et al
   Validating Risk Prediction Models for Multiple Primaries and Competing Cancer Outcomes in Families With Li-Fraumeni Syndrome Using Clinically Ascertained Data.
   J Clin Oncol. 2024;42:2186-2195.
   PubMed     Abstract available
   
   
   
9. MIKOLAJEWICZ N, Yee PP, Bhanja D, Trifoi M, et al
   Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application.
   J Clin Oncol. 2024;42:1961-1974.
   PubMed     Abstract available
   
   
   April 2024
10. MAURA F, Rajanna AR, Ziccheddu B, Poos AM, et al
    Genomic Classification and Individualized Prognosis in Multiple Myeloma.
    J Clin Oncol. 2024;42:1229-1240.
    PubMed     Abstract available
    
    
    
11. SHRIVER SP, Adams D, McKelvey BA, McCune JS, et al
    Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology.
    J Clin Oncol. 2024;42:1181-1192.
    PubMed     Abstract available
    
    
    February 2024
12. TRAVIS LB, Feldman DR, Fung C, Poynter JN, et al
    Adolescent and Young Adult Germ Cell Tumors: Epidemiology, Genomics, Treatment, and Survivorship.
    J Clin Oncol. 2024;42:696-706.
    PubMed     Abstract available
    
    
    January 2024
13. RICCIUTI B, Lamberti G, Puchala SR, Mahadevan NR, et al
    Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2024 Jan 11:JCO2300580. doi: 10.1200/JCO.23.00580.
    PubMed     Abstract available
    
    
    December 2023
14. JAGSI R, Griffith KA, Harris EE, Wright JL, et al
    Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA.
    J Clin Oncol. 2023 Dec 7:JCO2302270. doi: 10.1200/JCO.23.02270.
    PubMed     Abstract available
    
    
    November 2023
15. MANDELKER D, Marra A, Zheng-Lin B, Selenica P, et al
    Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma.
    J Clin Oncol. 2023;41:5151-5162.
    PubMed     Abstract available
    
    
    
16. KILBRIDE M, Egleston BL, Chung WK, Olopade O, et al
    Uptake of Genetic Research Results and Patient-Reported Outcomes With Return of Results Incorporating Web-Based Predisclosure Education.
    J Clin Oncol. 2023;41:4905-4915.
    PubMed     Abstract available
    
    
    August 2023
17. NARDONE V, Meirson T, De Felice F, Meattini I, et al
    Genomic Profiling: Can We Rely on Retrospective Analysis to Drive Changes in Clinical Practice?
    J Clin Oncol. 2023;41:3957-3958.
    PubMed    
    
    
    
18. ANDO Y, Terada T
    Consent in Pharmacogenetic Testing.
    J Clin Oncol. 2023;41:3875.
    PubMed    
    
    
    July 2023
19. STRACH MC, Mahon K, Barriuso J
    Genomic Subtypes of Appendiceal Adenocarcinoma: Enough to Guide Clinical Decision Making?
    J Clin Oncol. 2023;41:3559.
    PubMed    
    
    
    June 2023
20. SUBBIAH V, Kurzrock R
    Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: Genomics Is the Diagnosis.
    J Clin Oncol. 2023;41:3100-3103.
    PubMed    
    
    
    May 2023
21. KINNEY AY, Walters ST, Lin Y, Lu SE, et al
    Improving Uptake of Cancer Genetic Risk Assessment in a Remote Tailored Risk Communication and Navigation Intervention: Large Effect Size but Room to Grow.
    J Clin Oncol. 2023;41:2767-2778.
    PubMed     Abstract available
    
    
    January 2023
22. YU Y, Shi Q, Chen H
    Acquired Genomic Alterations From First-Line Anti-EGFR Chemotherapy in Advanced Colorectal Cancer: Improving Study Design and Data Analysis.
    J Clin Oncol. 2023 Jan 3:JCO2202296. doi: 10.1200/JCO.22.02296.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Genetics is free of charge.